Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€65.85
05.05.15
€83.00
22.07.15
19.78%
22.07.15

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€93.74
04.05.15
€110.00
29.06.15
11.35%
29.06.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
WuXi Pharmatech Inc. ADR

Start price
Target price
Perf. (%)
€38.48
30.04.15
€50.00
07.12.15
8.33%
07.12.15

buy
Innate Pharma

Start price
Target price
Perf. (%)
€15.59
29.04.15
€20.00
29.10.15
-15.84%
29.10.15

buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€1,432.5
16.04.15
€1,750.0
13.05.15
-30.19%
13.05.15

buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€5.60
14.04.15
€7.50
04.11.21
-89.13%
05.11.21

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€110.27
10.04.15
€150.00
27.07.15
7.47%
27.07.15

buy
Evotec SE

Start price
Target price
Perf. (%)
€3.77
31.03.15
€9.20
30.09.15
4.14%
30.09.15

buy
MEI Pharma Inc.

Start price
Target price
Perf. (%)
€36.00
24.03.15
€60.00
24.09.15
-12.50%
24.09.15

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€64.20
15.03.15
€68.00
15.09.15
-17.70%
15.09.15

buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€34.75
12.03.15
€50.00
14.09.15
-16.55%
14.09.15

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€61.31
11.03.15
€67.00
22.07.15
3.33%
22.07.15

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Top 10 in its market
buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€6.75
27.02.15
€19.00
16.06.15
-27.75%
16.06.15

buy
Novartis AG

Start price
Target price
Perf. (%)
€90.47
26.02.15
€100.00
07.12.15
-9.53%
07.12.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€89.15
26.02.15
€99.00
07.12.15
8.76%
07.12.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€15.80
24.02.15
€17.00
24.08.15
-19.62%
24.08.15

buy
Nanorepro AG

Start price
Target price
Perf. (%)
€1.61
19.02.15
€3.00
19.08.15
-29.72%
19.08.15

buy
Medicines Co.

Start price
Target price
Perf. (%)
€24.58
18.02.15
€28.00
07.09.15
45.81%
07.09.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€14.60
17.02.15
€15.80
24.02.15
9.25%
24.02.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€89.02
15.02.15
€130.00
07.12.15
8.86%
07.12.15

Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
positive Cash Flow expected
buy
Momenta Pharmaceuticals

Start price
Target price
Perf. (%)
€9.34
09.02.15
€10.30
13.02.15
8.64%
13.02.15

buy
Epirus Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€4.29
08.02.15
€5.70
13.02.15
43.03%
13.02.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€85.69
05.02.15
€100.00
18.03.15
7.04%
18.03.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Rockwell Medical Inc.

Start price
Target price
Perf. (%)
€101.04
03.02.15
€132.00
12.03.15
2.66%
12.03.15

buy
Pluristem Therapeutics Inc.

Start price
Target price
Perf. (%)
€27.37
02.02.15
€35.00
03.02.15
-8.66%
03.02.15